Skip to main content
. Author manuscript; available in PMC: 2022 Apr 16.
Published in final edited form as: Ann Surg. 2020 Oct 16;276(1):e40–e47. doi: 10.1097/SLA.0000000000004417

Table 3.

Physician opinions on the use of active surveillance in the management of thyroid cancer (N=448)

Survey Question N(%)
Is active surveillance an appropriate management options for some patients with thyroid cancer?
 Yes 336 (76%)
 No 105 (24%)
In your practice, do you currently recommend active surveillance in the management of thyroid cancer patients?
 Yes 190 (44%)
 No 247 (56%)
Which patients do you recommend management with active surveillance? Please select ALL that apply. (N=190)
 A 65-year-old female with a < 1 cm and no known lymph node involvement 135 (71%)
 A 40-year-old female with a < 1 cm and no known lymph node involvement 94 (49%)
 A 65-year-old female with a < 2 cm and no known lymph node involvement 60 (32%)
 A 40-year-old female with a < 2 cm and no known lymph node involvement 56 (30%)